Exact Sciences Announces Preliminary Fourth Quarter 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall Street rallies as Fed's Waller eases rate hike fears
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
Exact Sciences (EXAS) PT Raised to $161 at Oppenheimer
January 12, 2021 7:37 AM ESTOppenheimer analyst Kevin DeGreeter raised the price target on Exact Sciences (NASDAQ: EXAS) to $161.00 (from $153.00) while maintaining an Outperform rating.
The analyst commented, "Raising PT from $153 to $161 based on stronger-than-expected 4Q20 top-line growth(preliminary of $464.5-467.5M vs our prior estimate of $443.0M).... More
